Skip to main content

Advertisement

SpringerLink
Log in

Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

High levels of tumor necrosis factor (TNF) receptors (TNFRs; TNFR1 and TNFR2), markers of inflammation, have been reported as significant predictors of mortality in hemodialysis patients. Porphyromonas gingivalis is a major pathogenic bacterium involved in periodontitis, which induces systemic inflammation. We investigated the association between the abundance of P. gingivalis in saliva and serum TNFR levels in hemodialysis patients.

Methods

A cross-sectional study was conducted on 121 hemodialysis patients visiting a clinic in the Tokyo metropolitan area. Medical interviews and examinations, comprehensive dental examinations, bacterial examinations for P. gingivalis in saliva, and measurements of circulating TNFR levels were conducted. Multiple linear regression analysis was performed to evaluate the association between the number of P. gingivalis and circulating TNFR levels.

Results

TNFR1 and TNFR2 were positively correlated with high-sensitivity C-reactive protein (hsCRP). Severe periodontitis was significantly associated with the number of P. gingivalis in saliva but not serum TNFR levels. The number of P. gingivalis was significantly associated with both TNFR1 and TNFR2 levels in sera after adjusting for age, sex, body mass index, smoking status, history of diabetes, prior cardiovascular disease events, serum levels of hsCRP and albumin, and severity of periodontitis [for TNFR1: coefficient 0.76, 95% confidence interval (CI) 0.14–1.37, p = 0.02; for TNFR2: coefficient 0.95, 95% CI 0.09–1.80, p = 0.03].

Conclusion

Circulating TNFR levels are associated with the number of P. gingivalis in saliva after adjusting for relevant clinical factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sharma S, Sarnak MJ. Epidemiology: the global burden of reduced GFR: ESRD, CVD and mortality. Nat Rev Nephrol. 2017;13(8):447–8.

    Article  PubMed  Google Scholar 

  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.

    Article  CAS  PubMed  Google Scholar 

  3. Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med. 2010;363(19):1833–45.

    Article  CAS  PubMed  Google Scholar 

  4. Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9(5):255–65.

    Article  CAS  PubMed  Google Scholar 

  5. Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol. 2017;238:151–8.

    Article  PubMed  Google Scholar 

  6. Aukrust P, Sandberg WJ, Otterdal K, Vinge LE, Gullestad L, Yndestad A, et al. Tumor necrosis factor superfamily molecules in acute coronary syndromes. Ann Med. 2011;43(2):90–103.

    Article  CAS  PubMed  Google Scholar 

  7. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012;23(3):516–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Carlsson AC, Juhlin CC, Larsson TE, Larsson A, Ingelsson E, Sundström J, et al. Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes—findings from two community based cohorts of elderly. Atherosclerosis. 2014;237(1):236–42.

    Article  CAS  PubMed  Google Scholar 

  9. Carlsson AC, Nordquist L, Larsson TE, Carrero JJ, Larsson A, Lind L, et al. Soluble tumor necrosis factor receptor 1 is associated with glomerular filtration rate progression and incidence of chronic kidney disease in two community-based cohorts of elderly individuals. Cardiorenal Med. 2015;5(4):278–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Murakoshi M, Gohda T, Sonoda Y, Suzuki H, Tomino Y, Horikoshi S, et al. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy. Clin Exp Nephrol. 2017;21(6):1068–74.

    Article  CAS  PubMed  Google Scholar 

  11. Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, et al. Circulating TNF Receptors 1 and 2 predict mortality in patients with end-stage renal disease undergoing dialysis. Sci Rep. 2017;3(7):43520.

    Article  Google Scholar 

  12. Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36(3):261–70.

    Article  CAS  PubMed  Google Scholar 

  13. Omote K, Gohda T, Murakoshi M, Sasaki Y, Kazuno S, Fujimura T, et al. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol. 2014;306(11):F1335–47.

    Article  CAS  PubMed  Google Scholar 

  14. Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87(2):281–96.

    Article  CAS  PubMed  Google Scholar 

  15. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23(3):507–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Niewczas MA, Pavkov ME, Skupien J, Smiles A, Md Dom ZI, Wilson JM, et al. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med. 2019;25(5):805–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–20.

    Article  PubMed  Google Scholar 

  18. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277–90.

    Article  CAS  PubMed  Google Scholar 

  19. Demmer RT, Trinquart L, Zuk A, Fu BC, Blomkvist J, Michalowicz BS, et al. The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2013;8(10):e77441.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, et al. Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol. 2007;2(2):239–44.

    Article  CAS  PubMed  Google Scholar 

  21. Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis. 2006;47(5):815–22.

    Article  PubMed  Google Scholar 

  22. Franek E, Blaschyk R, Kolonko A, Mazur-Psonka L, Łangowska-Adamczyk H, Kokot F, et al. Chronic periodontitis in hemodialysis patients with chronic kidney disease is associated with elevated serum C-reactive protein concentration and greater intima-media thickness of the carotid artery. J Nephrol. 2006;19(3):346–51.

    CAS  PubMed  Google Scholar 

  23. Cholewa M, Madziarska K, Radwan-Oczko M. The association between periodontal conditions, inflammation, nutritional status and calcium-phosphate metabolism disorders in hemodialysis patients. J Appl Oral Sci. 2018;26:e20170495.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000. 2013;62(1):59–94.

    Article  PubMed  Google Scholar 

  25. Reynolds MA. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol 2000. 2014;64(1):7–19.

    Article  PubMed  Google Scholar 

  26. Thanakun S, Pornprasertsuk-Damrongsri S, Gokyu M, Kobayashi H, Izumi Y. Inverse association of plasma IgG antibody to aggregatibacter actinomycetemcomitans and high C-reactive protein levels in patients with metabolic syndrome and periodontitis. PLoS ONE. 2016;11(2):e0148638.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, et al. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS ONE. 2015;10(4):e0122212.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Gohda T, Nishizaki Y, Murakoshi M, Nojiri S, Yanagisawa N, Shibata T, et al. Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease. Diabetes Res Clin Pract. 2018;141:62–8.

    Article  CAS  PubMed  Google Scholar 

  29. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007;78(Suppl 7S):1387–99.

    Article  PubMed  Google Scholar 

  30. Korte DL, Kinney J. Personalized medicine: an update of salivary biomarkers for periodontal diseases. Periodontol 2000. 2016;70(1):26–37.

    Article  PubMed  Google Scholar 

  31. Bossola M. Xerostomia in patients on chronic hemodialysis: an update. Semin Dial. 2019;32(5):467–74.

    Article  PubMed  Google Scholar 

  32. Tervahartiala T, Koski H, Xu JW, Häyrinen-Immonen R, Hietanen J, Sorsa T, et al. Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res. 2001;80(6):1535–9.

    Article  CAS  PubMed  Google Scholar 

  33. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nie P, Li Z, Wang Y, Zhang Y, Zhao M, Luo J, et al. Gut microbiome interventions in human health and diseases. Med Res Rev. 2019;39(6):2286–313.

    Article  PubMed  Google Scholar 

  36. Taneja V. Sex hormones determine immune response. Front Immunol. 2018;9:1931.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. de Alencar JB, Zacarias JMV, Tsuneto PY, Souza VH, Silva COE, Visentainer JEL, et al. Influence of inflammasome NLRP3, and IL1B and IL2 gene polymorphisms in periodontitis susceptibility. PLoS ONE. 2020;15(1):e0227905.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Petersilka GJ, Ehmke B, Flemmig TF. Antimicrobial effects of mechanical debridement. Periodontol 2000. 2002;28:56–71.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Kuniha Konuma, Naho Kobayashi, Yuka Shiheido, Makoto Kaneko, Wataru Ono, Hiroki Sato, and Rie Kawamura for their assistance with data collection.

Funding

This study was supported by a Grant from the Japan Society for the Promotion of Science (Grant-in-Aid for Research Activity Start-up 18H06304 to R.M.) and in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Numbers 17K09711, 20K08617 to T.G.).

Author information

Authors and Affiliations

  1. Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    Risako Mikami, Koji Mizutani, Takanori Matsuura, Daisuke Kido, Kohei Takeda, Yuichi Izumi & Takanori Iwata

  2. Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan

    Tomohito Gohda

  3. Department of Internal Medicine, Saiyu Soka Hospital, Saitama, Japan

    Hiromichi Gotoh

  4. Department of Global Health Promotion, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    Yusuke Matsuyama & Takeo Fujiwara

  5. Division of Periodontology, Department of Oral Interdisciplinary Medicine, Graduate School of Kanagawa Dental University, Kanagawa, Japan

    Norio Aoyama

  6. Oral Care Perio Center, Southern TOHOKU General Hospital, Fukushima, Japan

    Yuichi Izumi

Authors
  1. Risako Mikami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koji Mizutani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohito Gohda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiromichi Gotoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yusuke Matsuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norio Aoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takanori Matsuura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Daisuke Kido
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kohei Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuichi Izumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takeo Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takanori Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RM, KM, TG, HG, YI, and TI developed the concept for this study. RM, KM, TG, HG, NA, TM, DK, and KT provided substantial assistance in data collection. RM, KM, TG, YM, and TF performed statistical analyses and wrote the initial draft of the manuscript. All authors reviewed the manuscript and approved its final version.

Corresponding author

Correspondence to Tomohito Gohda.

Ethics declarations

Conflict of interest

All the authors have declared no competing interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the Research Ethics Committee of Tokyo Medical and Dental University (D2014-126).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 254 kb)

10157_2020_1952_MOESM2_ESM.tif

Supplementary material 2 (TIFF 93 kb) Scatter plots between serum levels of TNFRs and hsCRP. TNFR1 and hsCRP were positively correlated (Spearman’s correlation coefficient = 0.26, p = 0.005) (a) TNFR2 and hsCRP were also positively correlated (Spearman’s correlation coefficient = 0.38, p <0.001) (b).

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mikami, R., Mizutani, K., Gohda, T. et al. Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study. Clin Exp Nephrol 25, 58–65 (2021). https://doi.org/10.1007/s10157-020-01952-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-020-01952-2

Keywords

Search

Navigation